YBX3 and cancer: Across 33 TCGA cancer types and six cancer subtypes, only LIHC showed a significantly positive correlation between YBX3 expression and the infiltration of all six immune cell types (neutrophils, macrophages, dendritic cells, CD8+ T cells, CD4+ T cells, and B cells).